• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A case of Dupilumab monotherapy in a patient with IgG4-related disease.

作者信息

Chen Yan, Zhao Jiahui, Liu Lingling

机构信息

Department of Dermatology, Peking University First Hospital, Beijing Key Laboratory of Molecular Diagnosis on Dermatoses, National Clinical Research Center for Skin and Immune Diseases, NMPA Key Laboratory for Quality Control and Evaluation of Cosmetics, Beijing, China.

出版信息

JAAD Case Rep. 2024 Mar 19;64:106-108. doi: 10.1016/j.jdcr.2024.03.007. eCollection 2025 Oct.

DOI:10.1016/j.jdcr.2024.03.007
PMID:40948683
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12423718/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2404/12423718/93a327aca5ef/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2404/12423718/382e9c897883/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2404/12423718/93a327aca5ef/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2404/12423718/382e9c897883/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2404/12423718/93a327aca5ef/gr2.jpg

相似文献

1
A case of Dupilumab monotherapy in a patient with IgG4-related disease.一例使用度普利尤单抗单药治疗IgG4相关疾病患者的病例。
JAAD Case Rep. 2024 Mar 19;64:106-108. doi: 10.1016/j.jdcr.2024.03.007. eCollection 2025 Oct.
2
Are there atypical sites of IgG4 related disease in head and neck region? Personal experience and literature review.头颈部IgG4相关疾病是否存在非典型部位？个人经验及文献综述。
Eur Arch Otorhinolaryngol. 2025 Jan 11. doi: 10.1007/s00405-024-09188-6.
3
IgG4-related disease involving distinctive areas of skull base: our experience.IgG4相关性疾病累及颅底不同区域：我们的经验
Eur Arch Otorhinolaryngol. 2025 May 30. doi: 10.1007/s00405-025-09479-6.
4
IgG4-related disease with interstitial nephritis in a patient with metastatic melanoma following immune checkpoint inhibitor treatment: a case report.免疫检查点抑制剂治疗后转移性黑色素瘤患者并发IgG4相关性疾病伴间质性肾炎：一例报告
BMC Rheumatol. 2025 Aug 1;9(1):95. doi: 10.1186/s41927-025-00548-1.
5
Efficacy and Safety of Dupilumab Monotherapy in Patients With Dystrophic Epidermolysis Bullosa: A Retrospective Study of 8 Cases.度普利尤单抗单药治疗营养不良型大疱性表皮松解症患者的疗效和安全性：8例回顾性研究
J Dermatol. 2025 Jul;52(7):1159-1165. doi: 10.1111/1346-8138.17753. Epub 2025 Apr 24.
6
Gene expression cluster differences and molecular correlation with the STING pathway in orbital MALT lymphoma and orbital IgG4-related eye disease.眼眶黏膜相关淋巴组织淋巴瘤和眼眶IgG4相关性眼病中基因表达簇差异及与STING通路的分子相关性
Discov Oncol. 2025 Aug 4;16(1):1466. doi: 10.1007/s12672-025-03239-y.
7
Retroperitoneal fibrosis in presence of autoimmune coagulation factor XIII deficiency result in recurrent critical post-operative hemorrhage: a case report and molecular research with new insights.自身免疫性凝血因子 XIII 缺乏症患者的腹膜后纤维化导致术后反复严重出血：一例报告及有新见解的分子研究
Front Immunol. 2025 Jul 10;16:1591847. doi: 10.3389/fimmu.2025.1591847. eCollection 2025.
8
A Case in Which the Endoscopic Denker's Approach Was Useful in the Diagnosis of IgG4-Related Ophthalmic Disease.内镜Denker入路在IgG4相关性眼病诊断中应用的1例病例
Cureus. 2025 Jun 26;17(6):e86809. doi: 10.7759/cureus.86809. eCollection 2025 Jun.
9
Sex as a predictor of clinical phenotype and determinant of immune response in IgG4-related disease: a retrospective study of patients fulfilling the American College of Rheumatology-European League Against Rheumatism classification criteria.性别作为 IgG4 相关疾病临床表型的预测因素和免疫反应的决定因素：符合美国风湿病学会-欧洲抗风湿病联盟分类标准的患者的回顾性研究。
Lancet Rheumatol. 2024 Jul;6(7):e460-e468. doi: 10.1016/S2665-9913(24)00089-4. Epub 2024 May 30.
10
[A rare case report of moderately differentiated adenosquamous carcinoma in the parotid gland associated with IgG4-related disease and literature review].[腮腺中分化腺鳞癌合并IgG4相关疾病1例罕见病例报告及文献复习]
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2025 Aug;39(8):749-753. doi: 10.13201/j.issn.2096-7993.2025.08.010.

本文引用的文献

1
IgG4-related disease administered dupilumab: case series and review of the literature.IgG4 相关疾病应用度普利尤单抗：病例系列和文献复习。
RMD Open. 2023 Mar;9(1). doi: 10.1136/rmdopen-2023-003026.
2
Allergic Aspects of IgG4-Related Disease: Implications for Pathogenesis and Therapy.IgG4 相关疾病的过敏方面：对发病机制和治疗的影响。
Front Immunol. 2021 Jul 7;12:693192. doi: 10.3389/fimmu.2021.693192. eCollection 2021.
3
Dupilumab: A Review of Present Indications and Off-Label Uses.度普利尤单抗：当前适应证及超说明书用药综述
J Investig Allergol Clin Immunol. 2022 Apr 19;32(2):97-115. doi: 10.18176/jiaci.0682. Epub 2021 Mar 3.
4
JAK Inhibition as a Therapeutic Strategy for IgG4-RD.JAK抑制作为IgG4相关性疾病的一种治疗策略。
J Investig Allergol Clin Immunol. 2021 Jun 22;31(3):280-281. doi: 10.18176/jiaci.0654. Epub 2020 Nov 25.
5
Correspondence on: 'Dupilumab as a novel steroid-sparing treatment for IgG-related disease' by Simpson .关于辛普森所著《度普利尤单抗作为一种用于IgG相关疾病的新型类固醇节省疗法》的通信
Ann Rheum Dis. 2022 Feb;81(2):e26. doi: 10.1136/annrheumdis-2020-217010. Epub 2020 Jan 29.
6
Interleukin-4 contributes to the shift of balance of IgG subclasses toward IgG4 in IgG4-related disease.白细胞介素 4 有助于 IgG4 相关疾病中 IgG 亚类向 IgG4 的平衡转移。
Cytokine. 2018 Oct;110:416-419. doi: 10.1016/j.cyto.2018.05.009. Epub 2018 May 31.
7
Type 2 immunity in tissue repair and fibrosis.组织修复和纤维化中的 2 型免疫。
Nat Rev Immunol. 2018 Jan;18(1):62-76. doi: 10.1038/nri.2017.90. Epub 2017 Aug 30.
8
International Consensus Guidance Statement on the Management and Treatment of IgG4-Related Disease.IgG4相关性疾病管理与治疗的国际共识指导声明
Arthritis Rheumatol. 2015 Jul;67(7):1688-99. doi: 10.1002/art.39132.
9
T helper 2 and regulatory T-cell cytokine production by mast cells: a key factor in the pathogenesis of IgG4-related disease.肥大细胞产生辅助性T细胞2和调节性T细胞细胞因子：IgG4相关疾病发病机制中的关键因素。
Mod Pathol. 2014 Aug;27(8):1126-36. doi: 10.1038/modpathol.2013.236. Epub 2014 Jan 3.
10
Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations.IgG4相关疾病及其各器官系统表现的命名建议。
Arthritis Rheum. 2012 Oct;64(10):3061-7. doi: 10.1002/art.34593.